These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 32361400

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.
    Hu YY, Du XY, Zhan AL, Zhou L, Jiang Q, Niu YM, Shen M.
    Oncotarget; 2016 Jul 26; 7(30):47711-47719. PubMed ID: 27351225
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Meta-analysis of association between the -2578C/A polymorphism of the vascular endothelial growth factor and retinopathy in type 2 diabetes in Asians and Caucasians.
    Wang H, Cheng JW, Zhu LS, Wei RL, Cai JP, Li Y, Ma XY.
    Ophthalmic Res; 2014 Jul 26; 52(1):1-8. PubMed ID: 24751925
    [Abstract] [Full Text] [Related]

  • 52. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.
    Hou Q, Li MY, Huang WT, Wei FF, Peng JP, Lou MW, Qiu JG.
    Oncotarget; 2017 Jul 25; 8(30):50061-50070. PubMed ID: 28562357
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk.
    Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ.
    Ther Clin Risk Manag; 2015 Jul 25; 11():237-45. PubMed ID: 25709466
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Polymorphism of VEGF-460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population.
    Sun SF, Huang DB, Cao C, Deng ZC.
    Med Oncol; 2013 Mar 25; 30(1):410. PubMed ID: 23288726
    [Abstract] [Full Text] [Related]

  • 59. Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population.
    Fu D, Li P, Cheng W, Tian F, Xu X, Yi X, Tang C, Wang Y, Hu Q, Zhang Z.
    Oncotarget; 2017 Apr 04; 8(14):22927-22935. PubMed ID: 28206971
    [Abstract] [Full Text] [Related]

  • 60. Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies.
    Liu L, Liu L, Zeng F, Wang K, Huang J, Xin L, Zhu PQ.
    J Cancer Res Clin Oncol; 2011 Jun 04; 137(6):1027-36. PubMed ID: 21174216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.